Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 22;17:2461–2479. doi: 10.2147/DDDT.S414098

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Ye et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

IGF-1 reversed ART B-induced apoptosis in H1299 cells. Cells were treated with ART B (30 μM) with or without IGF-1 (100 ng/mL) for 24 h. (A) The expression of PI3K, p-PI3K, Akt, p-Akt, BCL-2, BAX, PARP, c-PARP, c-CASP8, γ-H2A.X in H1299 cells were detected by Western blotting. (B) The statistical analyses of the related protein expressions. β-ACTIN was used as an internal control. Data are presented as mean ± SD (n = 3), **P < 0.01, and ***P < 0.001 vs control group. ^#P < 0.05, ^##P < 0.01, and ^###P < 0.001 vs the ART B treatment group. ns, P > 0.05 vs control group or the ART B treatment group.